AF Management Guideline Aligned
AF Alert Management: focus on the AF alerts that need your attention.
Implicity analyzes the atrial burden behind each alert, moves repeat alerts to the patient timeline, where they remain available for review, and raises a Smart Alert when a patient’s AF pattern changes. In a retrospective study of more than 4,000 patients, median AF alerts per patient-year fell by 57.9%.2
Atrial fibrillation alerts
AF alerts fill the queue. Few of them change the plan.
Atrial burden alerts are among the most common in CIED remote monitoring. Device thresholds are triggered by the number, without the context of each patient’s history. In a retrospective study, 67,883 AF burden alerts corresponded to 9,728 clinically relevant AF events (14.3%) under the ESC classification.2
The patient is already anticoagulated.
A threshold alert asks a question your team has already answered. It still has to be opened, read and closed.
The same AF, on every transmission.
Burden stays above threshold, so the alert keeps coming back, even when nothing about the patient’s AF has moved.
The real change looks like all the others.
When paroxysmal AF turns persistent, the alert reads much like the fortieth threshold alert before it.
~32 hours a month of AF alert review for a clinic following 1,000 patients, at two minutes per alert.3 Most of it goes to alerts not classified as clinically relevant.
Inside the workflow
Every Smart Alert arrives with the trend behind it.
Six AF scenarios can trigger a Smart Alert. Pick one to see what reaches your team, and what moves to the timeline.
- Your team sets the rules. Turn AF alert management on, choose whether manufacturer alerts are filtered, and choose whether Smart Alerts are triggered.
- Nothing disappears. Archived manufacturer alerts stay on the patient timeline, one click away.
- Context on one screen. The patient summary shows the current AF status with dates, synced with the burden trend graph.
- Easy to tell apart. Smart Alerts carry the Implicity mark, so the team knows where each one came from.
Illustrative examples. Trends, thresholds and patient details are not actual product screens or patient data.
Published evidence
reduction in median AF alerts per patient-year, in a retrospective study of more than 4,000 CIED patients under continuous AF monitoring.2
Devices in the study
FAQ
Questions clinics ask us most.
Does AF Alert Management delete manufacturer alerts?
No. Manufacturer AF burden alerts for anticoagulated patients are archived to the patient timeline instead of the review queue. They stay in the record and can be opened at any time.
How does it know whether a patient is anticoagulated?
It uses the anticoagulant medications recorded in the patient’s clinical data on the Implicity platform, alongside the raw atrial burden data from the device.
Which changes trigger a Smart Alert?
Six scenarios: a first recorded AT/AF episode, paroxysmal AF, increasing paroxysmal AF, persistent AF, the end of persistent AF with a return to paroxysmal AF, and the end of persistent AF with a return to sinus rhythm.
Can we choose what gets filtered?
Yes. Your team can turn AF alert management on or off, choose whether manufacturer alerts are filtered, and choose whether Smart Alerts are triggered.
Which devices does it work with?
The published evaluation included CIED patients under continuous AF monitoring with Abbott, Biotronik, Boston Scientific and Medtronic devices. Request a demo and we’ll confirm the fit for your device mix.
Does it replace clinical judgment?
No. Smart Alerts are advisory and are meant to be used alongside physician judgment. They are not a sole means of diagnosis.
How do we get started?
Request a demo and we’ll walk you through the setup and timing for your program.
- †IM007 ILR ECG Analyzer is an FDA cleared Class II medical device, see the instructions for use for more information.
- ‡SignalHF is an FDA cleared Class II medical device, see the instructions for use for more information.
- 1IM009 AF Alert Management is designed to align with U.S. atrial fibrillation treatment guidelines. It is intended as an adjunct to remote monitoring platforms, is advisory only, is not intended as a sole means of diagnosis, and does not replace physician judgment. Singh JP, Gentils M, Faedda G, Lazarus A, Mignot N, Mabo P. A Smart-Alert Algorithm for personalized management of CIED-detected atrial fibrillation: a multicenter study. Heart Rhythm. 2026. doi:10.1016/j.hrthm.2026.03.1725.
- 2Lazarus A, Gentils M, Klaes S, et al. Filtering of remote monitoring alerts transmitted by cardiac implantable electronic devices and reclassification of atrial fibrillation events by a new algorithm. Cardiovasc Digit Health J. 2023;4(5):149-154. doi:10.1016/j.cvdhj.2023.08.019. Retrospective study of more than 4,000 patients with Abbott, Biotronik, Boston Scientific or Medtronic CIEDs under continuous AF monitoring; AF events classified per the European Society of Cardiology (ESC) classification.
- 3Illustrative Implicity estimate: a clinic following 1,000 patients, reviewing each AF alert for 2 minutes. Actual alert volume and review time vary by practice.
The Implicity platform is a clinical decision support device and is in no way intended to replace the responsibility or clinical judgment of the practitioner. It is designed to optimize data workflows and support medical expertise in patient management. Smart Alerts are advisory and do not replace clinician review of device data.
